Dear Editor,
The initiation of DNA replication is a tightly controlled process, depending on the coordinated assembly and function of a specific set of proteins, the prereplicative complex (pre-RC) at chromosomal origin sequences. Integral components of this complex are Cdc6 and the six MCM proteins, Mcm2–7. MCM proteins may serve as replicative helicases. Once replication has started, reinitiation until the next round of the cell cycle is in part prevented by changes in the subcellular localization of Cdc6 and MCM proteins.1, 2 Limiting the availability of replication factors is thus an established pathway to prevent DNA replication.
Apoptosis is an important control mechanism to balance cell proliferation against cell death in development, differentiation and homeostasis in all multicellular organisms.3 Its ATP-dependent execution prevents the leakage of potentially harmful intracellular contents as seen in necrosis. Halting of ATP-consuming processes like DNA replication could therefore further the efficiency of apoptosis.4 Indeed, cleavage of replication proteins by caspases, the executioner proteases for apoptosis, has been reported.5
Here we show in detail the cleavage of the pre-RC proteins Mcm3 and Cdc6 by caspase-3 and caspase-7, including characterization of the cleavage sites. Localization as well as binding properties of the protein fragments generated in apoptotic cells are discussed, and a reinforcing proapoptotic mechanism for one of the Mcm3 fragments is described.
After the induction of apoptosis in the Burkitt's lymphoma cell line BL60-2, HeLa cells or the T cell line H9 by various stimuli, MCM proteins and Cdc6 were analyzed by immunoblotting. Proteolytic cleavage of Mcm3 and Cdc6 was observed in all cases (Figure 1a, upper and middle panel), while Mcm2 and Mcm4–7 remained unchanged (data not shown). The observed Mcm3 fragment has an apparent size of ∼90?kDa in agreement with previous reports.7, 8 The main cleavage product of Cdc6 had an apparent size of ∼45?kDa with a second fragment of ∼35?kDa appearing later in the apoptotic process (Figure 1a, middle panel). In response to each apoptotic stimulus, cleavage of replication initiation proteins was accompanied by activated caspase-3, the main executioner caspase in apoptotic cells (Figure 1a, lower panel). Further in vitro analysis using recombinant proteins identified caspase-3 and caspase-7 as the proteases capable to cleave Mcm3 and Cdc6 (see supplementary information). To identify the actual sites used for caspase cleavage, we performed site-directed mutagenesis of potential caspase recognition sites and assayed in vitro translated Cdc6 and Mcm3 protein fragments for proteolysis by recombinant caspase-3. For Mcm3, mutation of the aspartic acid corresponding to amino-acid 701 in the full-length protein to alanine resulted in the prevention of cleavage. A corresponding epitope tagged protein expressed in HeLa cells proved to be resistant to proteolysis (Figure 1b, upper panel). We therefore identified the caspase-3 site in Mcm3, used for cleavage in apoptotic cells, at DAKD701. The caspase cleavage sites in Cdc6 were identified in a similar manner. We were able to locate caspase-3 cleavage sites in Cdc6 at DEMD287 and SEVD442 and, again, overexpressed mutant proteins were not cleaved in apoptotic HeLa cells (Figure 1b, lower panel). Next, we tried to express recombinant forms of the Mcm3 cleavage products in addition to the caspase-resistant mutant of the protein. However, we could not detect the small C-terminal Mcm3 fragment in HeLa cells or any other cell line tested. For the other constructs, coimmunoprecipitation analysis showed interaction with the endogenous Mcm4 protein, indicative for the incorporation of the truncated or mutant Mcm3 forms in MCM complexes (Figure 1c). In addition, all of the overexpressed Mcm3 related proteins analyzed were shown to localize to the nucleus in HeLa cells (see supplementary information). These overexpression experiments also revealed a strong proapoptotic effect for the large N-terminal Mcm3 cleavage product (Mcm3 1–700), as monitored by fluorescence activated cell sorter analysis (FACS) for caspase activity (Figure 1d and experimental details therein). In contrast, transfection of the full-length Mcm3 constructs (either wild type or caspase resistant) induced only a moderate increase of caspase activity in this highly sensitive assay when compared to mock-transfected cells. This finding indicates a reinforcing proapoptotic activity for the apoptotic, N-terminal Mcm3 fragment that might be involved in the sustaining of signaling cascades or even enhance the execution of apoptosis.
In analogy to our Mcm3 approach, we generated expression vectors coding for the N- and C-terminal Cdc6 fragments as well as the full-length protein and its caspase-resistant counterpart (see Figure 1e for an overview of Cdc6 versions). In immunofluorescence experiments, the intracellular localization of full-length Cdc6, its uncleavable version as well as of the N-terminal fragment was either nuclear (colocalization with DAPI) or cytoplasmic. In contrast, the localization of the C-terminal fragment was exclusively cytoplasmic (see supplementary information), most likely as a result of the truncation of the nuclear localization signals located in the N-terminal part of Cdc6 (Figure 1e, see also Delmolino et al9). Interestingly, both the N- and C-terminal fragments generated upon induction of apoptosis in HeLa cells transfected with the wild-type Cdc6 expression construct localized exclusively to the cytoplasm (see supplementary information). To further characterize the apoptotic Cdc6 fragments and the cleavage-resistant Cdc6, we analyzed their capability to bind chromatin in comparison to wild-type Cdc6, when overexpressed in starved murine embryonal fibroblasts, which downregulate the endogenous Cdc6 protein.10 All versions of the Cdc6 protein that were localized to the nucleus (see above) were able to bind to chromatin (Figure 1e).
While this work was in progress, an additional caspase-3 cleavage site in the Cdc6 protein was reported at LVFD99.11 We therefore tried to visualize the corresponding apoptotic Cdc6 fragment of ∼52?kDa described. The fragment was not detectable in apoptotic cell extracts with our anti-Cdc6 antibody, which binds in the N-terminal half of the protein. It was also not visible after generation of radiolabeled full-length Cdc6 in a coupled in vitro transcription/reticulocyte lysate translation system and subsequent cleavage of the protein with recombinant caspase-3, circumventing the use of antibodies. Only one large fragment of about 45?kDa was generated from wild-type Cdc6 (data not shown). In addition, we overexpressed in HeLa cells both wild-type Cdc6 and the caspase-resistant Cdc6 protein, each epitope tagged at both the N- and C-terminus. After induction of apoptosis, cell extracts were analyzed by immunoblots using the epitope-directed antibodies. Again, only the fragments observed before could be identified (see supplementary information). Using the experimental conditions in our study, this excludes apoptotic Cdc6 cleavage sites other than DEMD287 and SEVD442.
Taken together, we were able to show cleavage of the pre-RC components Mcm3 and Cdc6 in different cell lines in response to various apoptotic stimuli. Mechanistically, such a process could ensure the inhibition of DNA replication in dying cells, thus preserving ATP for the apoptotic processes. The latter is likely to be important as ATP depletion was shown to switch apoptotic to necrotic cell death with its known side effects.3 Furthermore, we were able to show a reinforcing proapoptotic function for the large apoptotic Mcm3 fragment. Therefore, the cleavage of Mcm3 might have a function in apoptosis per se, exceeding the inhibition of DNA replication.
References
Bell SP and Dutta A (2002) Annu. Rev. Biochem. 71: 333–374
Yim H et al (2003) Mol. Biol. Cell 14: 4250–4259
Leist M and Nicotera P (1997) Biochem. Biophys. Res. Commun. 236: 1–9
Grusch M et al (2002) Cell Death Differ. 9: 169–178
Fischer U, Janicke RU and Schulze-Osthoff K (2003) Cell Death Differ. 10: 76–100
Rickers A et al (1999) Eur. J. Biochem. 261: 269–274
Schwab BL et al (1998) Exp. Cell Res. 238: 415–421
Yin MB et al (1999) Int. J. Cancer 83: 341–348
Delmolino LM, Saha P and Dutta A (2001) J. Biol. Chem. 276: 26947–26954
Cook JG et al (2002) Proc. Natl. Acad. Sci. USA 99: 1347–1352
Pelizon C et al (2002) EMBO Rep. 3: 780–784
Acknowledgements
We thank Ute Nitschke and Björn Lamprecht for excellent technical support. We also thank Dr. Cristina Pelizon for discussion of our results. This work was supported by grants from the DFG (to MG) and the Fonds der Chemischen Industrie (to MG).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary information accompanies this paper on the Cell Death and Differentiation website: http://www.nature.com/cdd
Supplementary information
Rights and permissions
About this article
Cite this article
Schories, B., Engel, K., Dörken, B. et al. Characterization of apoptosis-induced Mcm3 and Cdc6 cleavage reveals a proapoptotic effect for one Mcm3 fragment. Cell Death Differ 11, 940–942 (2004). https://doi.org/10.1038/sj.cdd.4401411
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cdd.4401411
This article is cited by
-
Up-regulation of MCM3 Relates to Neuronal Apoptosis After Traumatic Brain Injury in Adult Rats
Cellular and Molecular Neurobiology (2017)
-
Widdrol activates DNA damage checkpoint through the signaling Chk2–p53–Cdc25A–p21–MCM4 pathway in HT29 cells
Molecular and Cellular Biochemistry (2012)